Increased levels of Vascular Cell Adhesion Molecule-1 (VCAM-1) and Inter-Cellular Adhesion Molecule-1 (ICAM-1) Correlate with Advanced Disease Features and Poor Survival in Newly Diagnosed Patients with Multiple Myeloma. Reduction Post-Bortezomib-and Lenalidomide-Based Regimens.
Increased levels of Vascular Cell Adhesion Molecule-1 (VCAM-1) and Inter-Cellular Adhesion Molecule-1 (ICAM-1) Correlate with Advanced Disease Features and Poor Survival in Newly Diagnosed Patients with Multiple Myeloma. Reduction Post-Bortezomib-and Lenalidomide-Based Regimens.
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2009
Authors:
Migkou, Magdalini Terpos, Evangelos Christoulas, Dimitrios Gavriatopoulou, Maria Boutsikas, Georgios Gkotzamanidou, Maria Iakovaki, Marina Kastritis, Efstathios Papatheodorou, Athanasios Dimopoulos, Meletios A
